健康大视野·医学分册2023,Issue(6) :71-73.DOI:10.3969/j.issn.1005-0019.2023.06.027

硝苯地平联合厄贝沙坦治疗高血压的效果分析

刘兴义
健康大视野·医学分册2023,Issue(6) :71-73.DOI:10.3969/j.issn.1005-0019.2023.06.027

硝苯地平联合厄贝沙坦治疗高血压的效果分析

刘兴义1
扫码查看

作者信息

  • 1. 山东省平邑县妇幼保健院,山东 平邑 273300
  • 折叠

摘要

目的:探究硝苯地平联合厄贝沙坦治疗高血压的效果.方法:选取2021年3月至2022年3月在我院治疗的88例老年高血压患者,随机分为对照组与观察组各44例,对照组给硝苯地平治疗,观察组给硝苯地平联合厄贝沙坦治疗.结果:血压控制总有效率:对照组为81.82%,观察组为97.73%,观察组明显高于对照组,差异明显(P < 0.05);超声心动图相关指标差异明显(P < 0.05);不良反应:观察组头痛1例、乏力2例,不良反应率为6.82%;对照组头痛3例,乏力5例,机体水肿4例,不良反应率为27.27%,观察组

Abstract

Objective To investigate the effect of nifedipine combined with irbesartan on hypertension.Methods: 88 elderly patients with hypertension who were treated in our hospital from March 2021 to March 2022 were randomly divided into the control group and the observation group with 44 cases each. The control group was treated with nifedipine,and the observation group was treated with nifedipine combined with irbesartan.Results: The total effective rate of blood pressure control was 81.82% in the control group and 97.73% in the observation group,which was significantly higher than that in the control group (P<0.05); There were significant differences in echocardiographic indexes (P<0.05); Adverse reaction: 1 case of headache and 2 cases of fatigue in the observation group,with an adverse reaction rate of 6.82%; In the control group,there were 3 cases of headache,5 cases of fatigue and 4 cases of body edema. The adverse reaction rate was 27.27%. The adverse reaction rate in the observation group was significantly lower than that in the control group (P<0.05).Conclusion: Nifedipine combined with irbesartan can significantly control the blood pressure of patients with hypertension. The clinical treatment effect is better,and the application value is high,which is worth popularizing.

关键词

硝苯地平/厄贝沙坦/高血压

Key words

Nifedipine/Irbesartan/hypertension

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量10
段落导航相关论文